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Abstract
Objectives Previous meta-analyses on CT-colonography
included both average and high risk individuals, which
may overestimate the diagnostic value in screening. A
meta-analysis was performed to obtain the value of CT-
colonography for screening.
Methods A search was performed using PubMed, Embase
and Cochrane. Article selection and critical appraisal was
done by two reviewers. Inclusion criteria: prospective,
randomized trials or cohort studies comparing CT-
colonography with colonoscopy (≥50 participants), ≥95%
average risk participants ≥50 years. Study characteristics
and 2×2 contingency Tables were recorded. Sensitivity
and specificity estimates were calculated per patient and
per polyp (≥6 mm, ≥10 mm), using univariate and
bivariate analyses.
Results Five of 1,021 studies identified were included,
including 4,086 participants (<1% high risk). I
2-values
showed substantial heterogeneity, especially for 6–9m m
polyps and adenomas: 68.1% vs. 78.6% (sensitivity per
patient). Estimated sensitivities for patients with polyps or
adenomas ≥6 mm were 75.9% and 82.9%, corresponding
specificities 94.6% and 91.4%. Estimated sensitivities for
patients with polyps or adenomas ≥10 mm were 83.3% and
87.9%, corresponding specificities 98.7% and 97.6%.
Estimated sensitivities per polyp for advanced adenomas
≥6 mm and ≥10 mm were 83.9% and 83.8%.
Conclusion Comparedtocolonoscopy, CT-colonographyhas
a high sensitivity for adenomas ≥10 mm. For (advanced)
adenomas ≥6 mm sensitivity is somewhat lower.
Keywords Colorectal cancer.Screening.
CT-Colonography.Colonoscopy.Sensitivity and specificity
Introduction
Computed tomography (CT)-colonography has been stud-
ied for screening for (precursors of) colorectal cancer
(CRC) and the Multisociety Task Force on Colorectal
Cancer has indicated CT-colonography as an acceptable
technique for CRC screening [1, 2]. However, recently the
National Institute of Health has published a statement
regarding CRC screening concluding that there is still lack
of information regarding the use of CT-colonography as
screening technique in an average risk population [3]. Also
other guidelines state that there is insufficient evidence yet
[4, 5].
Several meta-analyses have been published on the
diagnostic value of CT-colonography including both aver-
age risk and high risk individuals, but no meta-analysis has
been published including average risk individuals only [6–
10]. Individuals are considered to be at average risk if
they have no symptoms, no personal history of CRC,
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family history of advanced neoplasia [11]. By including
studies containing high risk populations, the diagnostic
value of CT-colonography in an average risk population
might be overestimated. It is known that the estimated
diagnostic value of a technique depends on factors such as
disease prevalence and spectrum.
Therefore,the aim ofthismeta-analysiswas toestimatethe
diagnostic value of CT-colonography to detect (advanced)
adenomas and CRC in an average risk population aged 50–
75 years.
Materials and methods
Literature search
Articles were obtained from the electronic databases
PubMed, Embase and Cochrane, without restrictions with
respect to the publication date and language. Lists of
synonyms for CT-colonography were produced (Fig. 1) and
combined using the Boolean operator “OR”. The same was
done for colonoscopy. Both search results were combined,
using the Boolean operator “AND”. By reading title and
abstract of all retrieved articles, two observers identified
possible relevant papers, based on the inclusion and
exclusion criteria described below. The remaining articles
were retrieved as full-text articles and independently
checked by two reviewers. Disagreement regarding inclu-
sion was resolved by consensus. Reference lists of the final
selection of articles were checked manually to identify
other relevant papers. If additional information of an article
considered for inclusion was needed due to incomplete data
or description of the methods, the corresponding authors
were contacted.
Inclusion and exclusion criteria
Inclusion criteria were prospective, randomized trials or
cohort studies, in humans ≥50 years, in which at least 50
predominantly asymptomatic average risk subjects (≥95%)
underwent CT-colonography and completed colonoscopy
for verification within 3 months. In addition, eligible
studies needed to report the detection of colorectal polyps
(adenomatous and non-adenomatous), advanced neoplasia
and CRC and should include true-positive (TP), false-
positive (FP), true-negative (TN) and false-negative (FN)
values. Studies that included predominantly high risk
subjects (symptomatic, history of hereditary CRC, personal
history of polyps, CRC or IBD) were excluded, as well as
studies that performed CT-colonography as a consequence
of incomplete colonoscopy or studies that only performed
colonoscopy after positive findings on CT-colonography.
Quality assessment
Systematic assessment of quality and documentation of
relevant data of the selected articles was performed
independently by two reviewers, using a standardized form.
To grade the study quality, the Quality Assessment of
Diagnostic Accuracy Studies (QUADAS) tool was used
with special focus on the characteristics of the included
study population, index test and reference test [12]. We
assessed whether the inclusion and exclusion criteria were
described clearly and would result in a representative
screening cohort. In addition,the presence of a disease
progression bias and a verification bias was determined: did
all participants receive their reference test <3 months?
Furthermore, we assessed whether the index test did not
form part of the reference standard, whether all subjects
received the same reference test, if the test results of both
test were interpreted without knowledge of the other test
results and whether withdrawals or uninterpretable test
results were reported. Results are presented in Appendix 1.
Study population
The following patient characteristics were documented:
number of asymptomatic and symptomatic subjects, sex
ratio, mean or median age with age range and CT-
colonography indication.
Imaging features
The following characteristics were documented regarding
the imaging features of CT-colonography: bowel prepara-
tion, dietary restrictions, tagging and bowel distention, use
of spasmolytical drugs and type of CT-system and CT-
parameters, the positioning of the patient and the use of
intravenous contrast medium during CT-colonography. For
colonoscopy, the type of bowel preparation and dietary
restrictions were documented.
Imaging and diagnostic criteria
The following characteristics were documented regarding
image analysis of both CT-colonography and colonoscopy:
numberofdiagnosticexaminations,numberandexperienceof
CT-colonography readers and endoscopists, reading strategy
on CT-colonography, use of segmental unblinding or second
look colonoscopy, determination of size on CT-colonography
and during colonoscopy and histopathological confirmation.
Data extraction
For the analysis per patient, 2×2 contingency tables were
constructed to be able to calculate the sensitivity and
1748 Eur Radiol (2011) 21:1747–1763specificity values for the following type of lesions: all
polyps, adenomatous polyps, advanced adenomas (defined
as an adenoma with >25% villous features, size ≥10 mm
and/or high grade dysplasia [13]), advanced neoplasia and
CRC. For each type of lesion, except for CRC, data were
collected using the following thresholds: 6–9m m ,≥6m m
and ≥10 mm, based on the associated potential CRC risk
[14–16].
For the analysis per polyp, we extracted TP and FN
findings to calculate the sensitivity of all polyps, (advanced)
adenomas and advanced neoplasia for the same thresholds.
If needed, a request for additional data was send to the
corresponding author. If possible, the following matching
algorithm was used: the lesion should be at least <50%
margin of error in size and should be found in the same or
adjacent segment.
Statistical analysis
Heterogeneity of sensitivity or specificity was assessed
using I
2 statistics [17]. If I
2 values were >25%, we
considered these data significantly heterogeneous, and
random-effects analyses were performed. In case of
I
2-values <25%, fixed-effects approaches were used.
For the per-patient analyses, we used bivariate models
[18] to obtain summary estimates of sensitivity and
specificity with 95% confidence intervals. For the per-
polyp analyses, we used univariate models to obtain
summary estimates of sensitivity with 95% confidence
intervals. All analyses were performed using SAS software
(SAS 9.2 procNlmixed, SAS Institute, Cary, NC, USA).
Publication bias was examined by constructing funnel
plots.
Per patient The x-axis consisted of the natural logarithm of
the diagnostic odds ratio ¼ TP   TN ðÞ = FN   FP ðÞ ðÞ .O n
the y-axis, we plotted the number of patients.
Per-lesion The x-axis consisted of the sensitivity and on
the y-axis, we plotted the number of patients.
Egger’s regression tests were used to examine the
asymmetry of the funnel plots. A significant regression
coefficient (P<0.05) indicates an association between
sample size and the diagnostic values.
PubMed 
920 results 
Embase 
881 results 
Cochrane 
40 results 
PubMed, Embase, Cochrane 
1841 results in total 
1828 studies excluded 
820 duplicate studies 
1008 did not match inclusion/exclusion criteria  
(based on screening title and abstract, by 2 independent readers) 
13 full text articles 
Scored for validity and relevance by 2 independent readers 
7 articles excluded 
- predominantly high risk participants (n=5) 
-  reference test was performed, only if index test was positive (n=2) 
6 articles (describing 5 different studies) eligible for review 
Produce list of synonyms 
(Colonography (includes: CT colonography, CT colonography screening, virtual colonography) OR colography OR 
CTC OR computerized tomographic colonoscopy OR virtual colonoscopy OR virtual endoscopy OR ct colonoscopy 
OR ct pneumocolon) 
AND 
(Colonoscopy (includes:optical colonoscopy) OR coloscopy OR OC)
Fig. 1 Flowchart of search
strategy, search date: 21st of
July, 2010
Eur Radiol (2011) 21:1747–1763 1749Results
The initial search yielded 1,841 articles (Fig. 1). By excluding
doubles, 1,021 articles remained. After screening on title and
abstract, 1,008 articles were excluded. The most frequent
reasons for exclusion were study design, study population (i.e.
high risk) or non-related to CT-colonography or screening for
polyps and CRC (i.e. IBD, MR-colonography). After assess-
ment of 13 full text publications, seven articles were excluded,
because they included only (n=2)[19, 20]o rp r e d o m i n a n t l y
(n=4) high risk participants (16.7%, 37.0%, 76.6% and
80.4%, respectively)[21–24] or because colonoscopy was
only offered to a small selection of the participants (n=1)
[25]. Finally, six articles were included in this systematic
review describing the results found in five prospective cohort
studies [26–31]. Screening of title and abstract of references
and related articles did not result in additional relevant articles.
Patient characteristics
Patient characteristics are outlined in Table 1. We included
five studies with in total 4,086 patients (54% male). Four
studies [26–28, 30, 31] did have a study population of over
200 average risk subjects, the largest population comprised
2,249 average risk subjects [27]. The smallest study had a
population of 68 participants at average risk [29]. All
studies provided a clear description of patient character-
istics and the inclusion and exclusion criteria. Three studies
included high risk subjects: 2.6% [30, 31], 5.2% [28] and
11.3% [27], respectively. The corresponding authors of
these papers were contacted to obtain data concerning
average risk patients only. This succeeded in two out of
three studies, resulting in a total of four datasets containing
data of average risk subjects only [26–29] and one study
including 2.6% high risk participants [30, 31]. Resulting in
a total of 4,086 participants, of which 37 were at high risk
(0.9%). The mean age varied between 55 and 60.5 years,
the minimal age was 50 in four studies [26–29].
Bowel preparation and CT-colonography procedure
Bowel preparation and CT-colonography procedure are
outlined in Appendix 2.
Three studies used an extensive bowel preparation
predominantly based on 4 liters polyethylene glycol [26–
28] combined with a clear liquid diet [26], a low-residue
diet [28] or dietary restrictions depending on the institu-
tional standard of the clinical centres where the examina-
tions were done [27]. The remaining two studies both used
a more limited preparation based on sodium phosphate [29–
31]. One study combined this with a clear liquid diet [30,
31], the dietary restrictions of the other study were not
specified [29].
Three studies used oral tagging [26, 27, 30, 31], one
study did use intravenous contrast medium [28]. Of one
study it was not specified whether the participants received
tagging [29]. Bowel preparation was the same for colono-
scopy, as both colonoscopy and CT-colonography were
performed on the same day in all studies.
Bowel distension methods varied between the studies.
Two studies used (primarily) automated CO2 insufflation,
combined with butylscopolamine bromide (Buscopan,
Boehringer, Ingelheim, Germany) [26] or glucagonhydro-
chloride (GlucaGen, Novo Nordisk A’S, Bagsvaerd,
Denmark) as spasmolytical drug [27]. Three studies used
manual room air [28–31]. In one study no spasmolytical
drug was administered [28], it was not specified whether
spasmolytical drugs were used in the remaining two studies
[29–31]. Two studies used at least 4 slice CT equipment
[29–31], two studies used at least 16 slice CT [27, 28] and
one study used 64 slice CT [26].
Study characteristics
Study characteristics are outlined in Appendix 3.A l l
participants received CT-colonography and colonoscopy on
the same day. Different reference standards were used. One
study used the colonoscopy results without knowledge of the
CT-colonography findings [29], two studies used the
colonoscopy result after segmental unblinding as reference
[26, 30, 31], one study used colonoscopy (followed by a
second look colonoscopy if lesions ≥10 mm reported on
CTC were missed on the initial colonoscopy) combined with
histopathology as reference [27] and another study used the
histopathology results of the polyps that were removed
during colonoscopy after segmental unblinding [28]. It is
unclear whether there were any withdrawals in the selected
studies. Uninterpretable results of CT-colonography or
colonoscopy (outlined in Table 1) were reported and
excluded from the analyses in two studies [26, 30, 31].
Image analysis
The characteristics of the readers and the reading strategy
are outlined in Appendix 3. The minimal experience of the
CT-colonography readers was specified in four out of five
studies, and varied between 25 and 100 examinations [26–
28, 30, 31]. In one study the only reader had 5 years of
reading experience [29]. Two studies used 2D read as
primary reading strategy [28, 29], two studies used 3D read
[26, 30, 31] and one study used both reading strategies at
random [27]. None of the included studies specified whether
CADwas used.The experienceoftheendoscopistsanduse of
different scopes of the included studies was not specified in
most studies [27, 29–31]. One study had been done by
gastroenterologists with a minimum experience of 1,000
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Eur Radiol (2011) 21:1747–1763 1751colonoscopies [26], while the gastroenterologists in another
study had a prior experience of 3,000 colonoscopies [28].
Size measurement of the polyp was done by the use of
an open biopsy forceps [26, 28, 29], by a calibrated linear
probe [30, 31] or determined by the pathologist [27]. In all
studies histopathology confirmation was available.
Data extraction
Four studies used a matching algorithm almost the same as
the one described in the methods [26, 28–31]. These studies
considered a CT-colonography finding to correspond with a
colonoscopy lesion, if it was found in the same or adjacent
segment. In addition it should be at least <50% margin of
error in size [28], in the same or adjacent size category [26,
30, 31] or should have a size difference of <4 mm [29]t o
be considered as a true positive. The fifth study [27] used a
different matching algorithm: one or more lesions should be
in the same size category, irrespective of location. Of this
study new data were requested and received, using the
matching algorithm as specified in the methods section.
Per patient data for each of the different size categories
regarding all polyps and adenomas respectively, could be
obtained in three respectively four of the five studies
(Table 2). Per polyp data for each of the different size
categories regarding all polyps could be obtained in all
studies while per polyp data for adenomas could be
obtained in four studies and per polyp data of advanced
adenomas and CRC in three of the five studies (Table 3).
Corresponding I
2 values for heterogeneity are reported in
Tables 2 and 3. The results of individual studies are shown
in forest plots (Figs. 2 and 3).
Table 2 Results regarding all polyps, (advanced) adenomatous polyps, colorectal cancer, advanced neoplasia: per patient
All polyps (n=2,853)
6–9m m ≥6m m ≥10 mm
TP FP FN TN TP FP FN TN TP FP FN TN
Graser [26] N=307 25 6 4 272 50 10 6 241 25 4 2 276
Johnson [27] N=2,249 78 58 51 2,062 156 75 70 1,948 78 17 19 2,135
Kim [28] N=229 23 14 15 177 36 20 17 156 13 6 2 208
Macari [29] N=68 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 3 1 0 64
Estimated sensitivity 68.1 (52.9–80.2) 75.9 (62.3–85.8) 83.3 (76.8–89.0)
I
2 heterogeneity
a 68.2% (29.2–85.7) 77.0% (46.0–90.2) 0.0% (0.0–82.0)
Estimated specificity 96.5 (93.9–98.0) 94.6 (90.4–97.0) 98.7 (97.6–99.3)
I
2 heterogeneity
a 83.7% (61.7–93.1) 90.4% (78.5–95.7) 60.1% (15.2–81.2)
Adenomatous polyps (n=4,018)
6–9m m ≥6m m ≥10 mm
TP FP FN TN TP FP FN TN TP FP FN TN
Graser [26] N=307 19 12 2 274 42 18 4 243 23 6 2 276
Johnson [27] N=2,249 62 61 30 2,096 137 78 45 1,989 75 17 15 2,142
Kim [28] N=229 22 6 11 190 31 18 12 168 9 12 1 207
Pickhardt [30, 31] N=1,233 104 170 16 943 149 217 19 848 45 47 3 1,138
Estimated sensitivity 78.6 (66.1–87.3) 82.9 (73.6–89.4) 87.9 (82.1–92.0)
I
2 heterogeneity
a 79.4% (54.2–90.8) 80.2% (56.0–91.1) 14.6% (0.0–87.0)
Estimated specificity 95.0 (89.7–97.6) 91.4 (84.1–95.5) 97.6 (95.0–98.9)
I
2 heterogeneity
a 98.1% (96.9–98.8) 98.4% (97.6–99.0) 92.5% (85.3–96.2)
Advanced adenomas ≥6 mm, advanced neoplasia ≥6 mm and CRC (n=2,785)
Advanced adenomas ≥6m m
c Colorectal cancer
c Advanced neoplasia ≥6m m
c
sensitivity sensitivity sensitivity
Graser [26] N=307 92.6% 100% 92.9%
Johnson [27] N=2,249 83.3% 100% 84.0%
Kim [28] N=229 87.5%
b 100% 88.2%
b
aIf I
2 values of sensitivity and/or specificity were larger than 25%, data were considered as significantly heterogeneous
bNo lesions <6 mm found
cNot possible to calculate estimated sensitivity and specificity due to small numbers, data regarding TP, FP, FN and TN values not available
1752 Eur Radiol (2011) 21:1747–1763Data analysis per patient
All polyps Estimated sensitivities for polyps ≥6 mm and ≥
10 mm (regardless of histology) were 75.9% (95%CI 62.3–
85.8) and 83.3% (95%CI 76.8–89.0), while corresponding
specificities were 94.6% (95%CI 90.4–97.0) and 98.7%
(95%CI 97.6–99.3).
Adenomas Estimated sensitivities for adenomas ≥6m m
and ≥10 mm were 82.9% (95%CI 73.6–89.4) and
Table 3 Results regarding all polyps, (advanced) adenomatous polyps, colorectal cancer and advanced neoplasia: per polyp
All polyps (n=4,086 participants)
6–9m m ≥6m m ≥10 mm
TP FN TP FN TP FN
Graser [26] N=307 49 7 84 9 35 2
Johnson [27] N=2,249 113 74 203 97 90 23
Kim [28] N=229 44 34 60 40 16 6
Macari [29] N=68 9 8 12 8 3 0
Pickhardt [30, 31] N=1,233 209 54 278 66 69 12
Estimated sensitivity 69.7 (56.2–80.6) 74.3 (61.6–83.8) 83.7 (76.6–89.0)
I
2 heterogeneity
a 88.6% (77.8–94.2) 89.3% (79.3–94.4) 33.3% (0.0–56.9)
Adenomatous polyps (n=4,018 participants)
6–9m m ≥6m m ≥10 mm
TP FN TP FN TP FN
Graser [26] N=307 37 4 67 6 30 2
Johnson [27] N=2,249 81 49 167 68 86 19
Kim [28] N=229 31 21 44 25 13 4
Pickhardt [30, 31] N=1,233 133 26 180 30 47 4
Estimated sensitivity 75.7 (60.3–86.5) 80.0 (66.9–88.7) 85.9 (80.4–90.0)
I
2 heterogeneity
a 88.5% (75.9–94.5) 89.2 (77.7–94.8) 44.9% (2.8–68.8)
Advanced adenomas (n=2,785 participants)
6–9m m ≥6m m ≥10 mm
TP FN TP FN TP FN
Graser [26] N=307 6 0 36 2 30 2
Johnson [27] N=2,249 0 0 86 19 86 19
Kim [28] N=229 6 2 19 6 13 4
Estimated sensitivity n.a. 83.9 (77.6–88.7) 83.8 (77.1–88.8)
I
2 heterogeneity
a n.a. 51.8 (16.2–72.3) 32.3% (0.0–93.0)
Colorectal cancer (n=2,785 participants)
6–9m m ≥6m m ≥10 mm
TP FN TP FN TP FN
Graser [26] N=307 0 0 1 0 1 0
Johnson [27] N=2,249 0 0 4 0 4 0
Kim [28] N=229 0 0 1 0 1 0
Not possible to calculate estimated sensitivity due to small numbers
Advanced neoplasia (n=2,785 participants)
6–9m m ≥6m m ≥10 mm
TP FN TP FN TP FN
Graser [26] N=307 6 0 37 2 31 2
Johnson [27] N=2,249 0 0 90 19 90 19
Kim [28] N=229 6 2 20 6 14 4
Not possible to calculate estimated sensitivity due to small numbers
aIf I
2 values of sensitivity and/or specificity were larger than 25%, data were considered as significantly heterogeneous
Eur Radiol (2011) 21:1747–1763 175387.9% (95%CI 82.1–92.0), while corresponding specif-
icities were 91.4% (95%CI 84.1–95.5) and 97.6%
(95%CI 95.0–98.9).Estimated sensitivities of all polyps
and adenomatous polyps of 6–9m ma r ea v a i l a b l ei n
Table 2.
Advanced adenomas, CRC and advanced neoplasia Estimated
results for the detection of advanced adenomas, advanced
neoplasia and CRC were not calculated, as a consequence of
the small number of participants with these findings (Table 2).
Data analysis per polyp
All polyps Estimated sensitivities for polyps ≥6m m
and ≥10 mm (regardless of histology), were 74.3%
(95%CI 61.6–83.3) and 83.7% (95%CI 76.6–89.0).
0,4 0,5 0,6 0,7 0,8 0,9 1
Sensitivity of CT-colonography for the detection of polyps, per patient 
(including 95% CI)
All polyps  10 mm
Johnson [27]
Pooled (I
2 = 77.0%)
Johnson [27]
Graser [26]
Kim [28]
Pooled (I
2 =0 . 0 % )
Macari [29]
Graser [26]
Kim [28]
All polyps   6 mm 
0,7 0,75 0,8 0,85 0,9 0,95 1
Specificity of CT-colonography for the detection of polyps, per patient 
(including 95% CI)
Johnson [27]
Graser [26]
Kim [28]
Pooled (I
2 = 90.4%)
Johnson [27]
Graser [26]
Kim [28]
Pooled (I
2 = 60.1%)
Macari [29]
All polyps   10 mm 
All polyps 6m m
Fig. 2 Forest plot of per patient
sensitivity and specificity,
including sensitivity and speci-
ficity estimates, for all polyps.
Summary statistics: estimated
sensitivities for polyps ≥6m m
and ≥10 mm were 75.9% (95%
CI 62.3–85.8) and 83.3% (95%
CI 76.8–89.0), corresponding
estimated specificities 94.6%
(90.4–97.0) and 98.7%
(97.6–99.3)
1754 Eur Radiol (2011) 21:1747–1763Adenomas Estimated sensitivities for adenomas ≥6m m
and ≥10 mm were 80.0% (95%CI 66.9–88.7) and 85.9%
(95%CI 80.4–90.0).
Advanced adenomas Estimated sensitivities for advanced
adenomas ≥6m ma n d≥10 mm were 83.9% (95%CI
77.6–88.7) and 83.3% (95%CI 77.1–88.8). Estimated
sensitivities for polyps and (advanced) adenomas of 6–
9 mm, are presented in Table 3.
Advanced neoplasia and CRC Estimated sensitivities for
advanced neoplasia and CRC by CT-colonography
were not calculated, as a consequence of the small
number of CRCs (n=6) that were detected in the
0,4 0,5 0,6 0,7 0,8 0,9 1
Sensitivity of CT-colonography for the detection of adenomas, per patient 
(including 95% CI)
Johnson [27]
Pickhardt [30,31]
Graser [26]
Pooled (I
2 = 80.2%)
Kim [28]
Adenomas  6 mm
Adenomas  10 mm
Johnson [27]
Pickhardt [30,31]
Graser [26]
Pooled (I
2 = 14.6%)
Kim [28]
0,7 0,75 0,8 0,85 0,9 0,95 1
Specificity of CT-colonography for the detection of adenomas, per patient 
(including 95% CI)
Johnson [27]
Pickhardt [30,31]
Graser [26]
Pooled (I
2 = 
Kim [28]
Adenomas  6 mm
 Adenomas  10 mm
Johnson [27]
Pickhardt [30,31]
Graser [26]
Pooled (I
2 = 
Kim [28]
Fig. 3 Forest plot of per patient
sensitivity and specificity,
including sensitivity and speci-
ficity estimates, for adenomas
Summary statistics: estimated
sensitivities for adenomas
≥6 mm and ≥10 mm were 82.9
(73.6–89.4) and 87.9 (82.1–
92.0), corresponding estimated
specificities 91.4 (84.1–95.5)
and 97.6 (95.0–98.9)
Eur Radiol (2011) 21:1747–1763 1755included studies. In all studies, no CRCs were missed
(Table 3).
Publication bias
The data points in the funnel plots are symmetrically
distributed in a funnel shape suggesting the absence
of publication bias (Appendix 4a–5b). In addition,
the Egger’s regression tests showed no associations between
sample size and diagnostic values (data not shown).
Discussion
This systematic review demonstrates an estimated per
patient sensitivity and specificity of CT-colonography for
the detection of adenomas ≥6 mm of 82.9% (95%CI 74–
89%) and 91.4% (95%CI 84–96%) in asymptomatic
screening participants. The estimated per patient sensitivity
and specificity for adenomas ≥10 mm, were 87.9% (95%CI
82–92%) and 97.6% (95%CI 95–99%). The estimated per
patient sensitivities for all colorectal polyps were slightly
lower. All six CRCs were detected by CT-colonography.
As we obtained additional data of the studies in which
high risk participants were excluded [27, 28], the study
results might not be identical to previously published data.
In addition, the results of Johnson et al. [27] are different
then published before, as we used a different matching
algorithm then the one that was used in their study,
resulting in lower sensitivities and higher specificities.
There are a few explanations available for the substantial
variability between studies in sensitivity and specificity.
The largest study [27]( n=2,249 participants), did not report
lesions <5 mm found on CT-colonography (while a
colonoscopy lesion of 6 mm could match a CTC lesion of
3 mm) and performed no second look colonoscopy for
colonoscopy negative CTC lesions <10 mm . Obviously,
both factors will probably result in a lower sensitivity for
medium sized adenomas and a less prominent difference in
the detection of adenomas ≥10 mm compared to the studies
of Graser [26]a n dP i c k h a r d t[ 30, 31]. The second
explanation could be the use of primary 2D or primary
3D read: those studies with the highest sensitivities for the
detection of adenomas used primary 3D read [26, 30, 31];
the other studies used primary 2D read [28, 29] or both
methods randomly [27]. However, there is conflicting
evidence regarding the possible difference of sensitivity
when using primary 2D or 3D read [32, 33].
To our knowledge this is the first meta-analysis in which
the diagnostic value of CT-colonography is compared to
colonoscopy for the detection of (adenomatous) polyps and
CRC in an average risk population. Previously, at least five
systematic reviews [6–10] were published describing the
diagnostic value of CT-colonography in general (not
specified for (advanced) adenomas), including both average
risk and high risk populations. By comparing our results to
the estimated sensitivities per patient for polyps 6–9m m
and ≥10 mm published previously, we found lower
sensitivities, especially when looking at polyps of 6–
9 mm. Estimated sensitivities per patient for polyps 6–
9 mm published before were 59%, 70%, 84% and 86%,
respectively [6–8, 10], while we calculated an estimated
sensitivity of 68.1%. Estimated sensitivities per patient for
polyps ≥10 mm were 76%, 85%, 88% and 93%, respec-
tively [6–8, 10], while we calculated an estimated sensitiv-
ity of 83.3%. The fifth meta-analysis reported results using
different thresholds [9].
Our study has several strengths. We aimed to use data on
average risk participants only and collected data regarding all
polyps, (advanced) adenomas and CRC. This provided the
possibility to estimate the diagnostic value of CT-
colonography for adenomas and CRC in a screening setting.
In order to perform an unbiased study selection, two
reviewers independently selected possible relevant articles.
Our study also has several limitations. Although we tried
to include only individuals at average risk, we could not
obtain these data from one study [30, 31]. Therefore, 37
individuals (0.9%) at high risk were included. However, it
is assumable that this will be daily practice in screening and
it is unlikely that this small number will have a substantial
impact on the results.
Secondly, participants of two studies comprised the
majority of included participants, which might give the
impression that this meta-analysis is actually a two study
meta-analysis. However, the results of the two largest
studies were heterogeneous and, moreover, were not at
one end of the spectrum of the sensitivity or specificity
range. Therefore it is unlikely that the larger studies skewed
the results in one direction (of higher or lower values).
Furthermore, sensitivity and specificity estimates were
calculated using statistical analyses in which the individual
studies are weighted by number of included participants
[18].
Thirdly, we did not calculate the negative predictive
value (NPV) because the prior probability of a negative
outcome was high [34].
Fourthly, it is known that colonoscopy is not 100%
sensitive for colorectal lesions and therefore no perfect
reference standard [35]. Using the colonoscopy results after
segmental unblinding and compared with histology, would
be the best reference standard.
Fifthly, because of limited data we were not able to
calculate estimated sensitivities per patient for the detection
of advanced adenomas, advanced neoplasia and CRC.
1756 Eur Radiol (2011) 21:1747–1763In summary, this meta-analysis of prospective studies
studying the diagnostic value of CT-colonography com-
pared to colonoscopy in an average risk population, shows
that CT-colonography has a good sensitivity for (advanced)
adenomas ≥10 mm. For (advanced) adenomas ≥6m m
sensitivity is somewhat lower.
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Appendix 1
Table 4 Quality assessment of all included studies using the QUADAS-tool
Graser,
2009 [26]
Johnson,
2008 [27]
Kim,
2008 [28]
Macari,
2004 [29]
Pickhardt,
2003 [30, 31]
Spectrum of patients representative of the patients who will receive
the test in practice?
Yes Yes Yes Yes Yes
Were selection criteria clearly described? Yes Yes Yes Yes Yes
Is the reference standard likely to correctly classify the target
condition?
Yes Yes Yes Yes Yes
Is the time period between reference standard and index test short
enough to prevent change of the target condition between the two
tests?
1
Yes, same
day
Yes, same
day
Yes, same
day
Yes, same
day
Yes, same
day
Did all subjects receive verification using a reference standard of
diagnosis?
Yes Yes Yes Yes Yes
Did all subjects receive the same reference standard regardless of
the index test result?
Yes Yes Yes Yes Yes
Was the reference standard independent of the index test? No
2 No, partly
3 No
2 Yes No
2
Execution of the index test described in sufficient detail to permit
replication?
Yes Yes Yes Yes Yes
Execution of the reference standard described in sufficient detail to
permit replication?
Yes Yes Yes Yes Yes
Were the index test results interpreted without knowledge of the
results of the reference standard?
Yes Yes Yes Yes Yes
Were the reference standard results interpreted without knowledge
of the results of the index test?
Yes Yes Yes Yes Yes
Were the same clinical data available when test results were
interpreted as would be available when the test is used in
practice?
Yes Yes Yes Yes Yes
Were uninterpretable/intermediate test results reported? Yes Yes, partly
4 Unclear Unclear Yes
Were withdrawals from the study explained? Unclear
5 Unclear
5 Unclear
5 Unclear
5 Unclear
5
VALID Yes Yes Yes Yes Yes
RELEVANT Yes Yes Yes Yes Yes
1Defined as <3 months.
2Reference standard=colonoscopy after segmental unblinding or second look colonoscopy
3Reference standard=colonoscopy followed by a second look colonoscopy if there was no match for polyps >9 mm on CT-colonography
4Of the 2,600 subjects recruited, 69 subjects were excluded in the analysis as a consequence of incomplete colonoscopy and/or CT-colonography results,
not further specified.
5In none of the studies was explained whether there were any withdrawals from the study.
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Fig. 4 a Funnel plot per patient, all polyps, b Funnel plot per patient,
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